Europe Liver Cancer Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Analysis – by Type (Laboratory Tests, Endoscopy, Imaging, Biopsy, and Others) and End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, and CRO Laboratories)

No. of Pages: 137    |    Report Code: BMIRE00025041    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Liver Cancer Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Liver Cancer Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Liver Cancer Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Diagnosis Due to Strategic Initiatives
  • 5.1.2 Increasing Liver Cancer Cases
5.2 Market Opportunities
  • 5.2.1 Increasing Research And Development (R&D) Expenditure
5.3 Future Trends
  • 5.3.1 Rising Emergence of New Technologies is the Trends Witnessed
5.4 Impact of Drivers and Restraints

6. Europe Liver Cancer Diagnostics Market Regional Analysis

6.1 Europe Liver Cancer Diagnostics Market Overview
6.2 Europe Liver Cancer Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Europe Liver Cancer Diagnostics Market Forecast Analysis

7. Europe Liver Cancer Diagnostics Market Analysis – by Type

7.1 Laboratory Tests
  • 7.1.1 Overview
  • 7.1.2 Laboratory Tests: Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Endoscopy
  • 7.2.1 Overview
  • 7.2.2 Endoscopy: Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Imaging
  • 7.3.1 Overview
  • 7.3.2 Imaging: Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Biopsy
  • 7.4.1 Overview
  • 7.4.2 Biopsy: Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Liver Cancer Diagnostics Market Analysis – by End User

8.1 Hospitals and Diagnostic Laboratories
  • 8.1.1 Overview
  • 8.1.2 Hospitals and Diagnostic Laboratories: Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Academic and Research Institutes
  • 8.2.1 Overview
  • 8.2.2 Academic and Research Institutes: Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 CRO Laboratories
  • 8.3.1 Overview
  • 8.3.2 CRO Laboratories : Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Liver Cancer Diagnostics Market – Europe Analysis

9.1 Europe
  • 9.1.1 Europe Liver Cancer Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 9.1.1.1 Europe Liver Cancer Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 UK: Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.1.1 UK: Europe Liver Cancer Diagnostics Market Breakdown, by Type
    • 9.1.1.1.2 UK: Europe Liver Cancer Diagnostics Market Breakdown, by End User
  • 9.1.1.2 Germany: Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.2.1 Germany: Europe Liver Cancer Diagnostics Market Breakdown, by Type
    • 9.1.1.2.2 Germany: Europe Liver Cancer Diagnostics Market Breakdown, by End User
  • 9.1.1.3 France: Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.3.1 France: Europe Liver Cancer Diagnostics Market Breakdown, by Type
    • 9.1.1.3.2 France: Europe Liver Cancer Diagnostics Market Breakdown, by End User
  • 9.1.1.4 Russia: Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.4.1 Russia: Europe Liver Cancer Diagnostics Market Breakdown, by Type
    • 9.1.1.4.2 Russia: Europe Liver Cancer Diagnostics Market Breakdown, by End User
  • 9.1.1.5 Italy: Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.5.1 Italy: Europe Liver Cancer Diagnostics Market Breakdown, by Type
    • 9.1.1.5.2 Italy: Europe Liver Cancer Diagnostics Market Breakdown, by End User
  • 9.1.1.6 Rest of Europe: Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.6.1 Rest of Europe: Europe Liver Cancer Diagnostics Market Breakdown, by Type
    • 9.1.1.6.2 Rest of Europe: Europe Liver Cancer Diagnostics Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Europe Liver Cancer Diagnostics Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Abbott
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 bioMerieux SA
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 F. HOFFMANN-LA ROCHE LTD.
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Illumina, Inc.
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Koninklijke Philips N.V.
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 QIAGEN
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Siemens Healthineers AG
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 THERMO FISHER SCIENTIFIC INC.
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 GE Healthcare
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
12.10 Perspectum
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - E Market

  1. Abbott
  2. bioMerieux SA
  3. F. HOFFMANN-LA ROCHE LTD.
  4. Illumina, Inc.
  5. Koninklijke Philips N.V.
  6. QIAGEN
  7. Siemens Healthineers AG
  8. THERMO FISHER SCIENTIFIC INC.
  9. GE Healthcare
  10. Perspectum
europe-liver-cancer-diagnostics-market